During the past decade, University of Tennessee / Hamilton Eye Institute conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Tennessee / Hamilton Eye Institute" #1 collaborator was "National Eye Institute (NEI)" with 1 trials as a collaborator, "National Institutes of Health (NIH)" with 1 trials as a collaborator and "United States Department of Defense" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "University of Tennessee / Hamilton Eye Institute" are "Retinitis Pigmentosa" (3 trials), "Glaucoma" (1 trials), "Glaucoma, Open Angle" (1 trials) and "Herpes Zoster Ophthalmicus" (1 trials). Many other conditions were trialed in "University of Tennessee / Hamilton Eye Institute" in a lesser frequency.

Most popular intervention types in "University of Tennessee / Hamilton Eye Institute" are "Drug" (4 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "NT-501" (2 trials), "Ahmed FP7 Glaucoma Valve" (1 trials), "Masked Oral Valacyclovir" (1 trials), "Masked Placebo" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Tennessee / Hamilton Eye Institute" are 5 trials for "All" genders.

Currently, there are NaN active trials in "University of Tennessee / Hamilton Eye Institute". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in University of Tennessee / Hamilton Eye Institute, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of Tennessee / Hamilton Eye Institute, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".